VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U4325AA: VAERS reports

24 VAERS reports list lot U4325AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2012-05-10 and 2013-10-10. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
46%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3940%
General / Systemic (non-local)2324%
Neurological1111%
Gastrointestinal77%
Musculoskeletal66%
Dermatological (non-injection-site)44%
Cardiac / Cardiovascular22%
Allergic / Anaphylactic22%
Thrombotic / Hematological11%
Respiratory11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Massachusetts3
Michigan2
Washington2
Pennsylvania2
Virginia2
South Carolina2
Wisconsin1
Georgia1
Iowa1
Florida1
New Jersey1
Kentucky1

Reports by month received

2012-057
2012-064
2012-072
2012-084
2012-093
2012-101
2012-112
2013-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.